Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shweta Bapat"'
Publikováno v:
Harm Reduction Journal, Vol 19, Iss 1, Pp 1-11 (2022)
Abstract Background Prescription opioids have been increasingly prescribed for chronic pain while the opioid-related death rates grow. Naloxone, an opioid antagonist, is increasingly recommended in these patients, yet there is limited research that i
Externí odkaz:
https://doaj.org/article/b69e3148b7304b479fd4f7e22975a59b
Autor:
Shweta Bapat, Micki Washburn, Vaishnavi Tata, Marc Fleming, Susan M. Abughosh, E. James Essien, Douglas Thornton
Publikováno v:
Substance usemisuse. 57(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9b5617ac5d85886ab7f650a564c9bb
https://pubmed.ncbi.nlm.nih.gov/35993387
https://pubmed.ncbi.nlm.nih.gov/35993387
Autor:
Pooja Upadhyay, Shweta Bapat
Publikováno v:
Social Responsibility Journal. 17:149-163
Purpose This paper aims to study the implications of corporate social responsibility (CSR) on employee engagement in selected Indian business giants to which CSR spending is mandatory as per the Companies Act 2013. Researcher also has an intention of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::555b8d6139db10e2e5e882265ed33ec2
https://doi.org/10.1108/srj-05-2018-0120
https://doi.org/10.1108/srj-05-2018-0120
Autor:
Precious Anyanwu, Tyler J. Varisco, Matthew A. Wanat, Shweta Bapat, Kasey Claborn, J. Douglas Thornton
Publikováno v:
Journal of painpalliative care pharmacotherapy. 36(2)
The objective of this study is to assess the differences in buprenorphine prescribers from a county level in the state of Texas by comparing the Substance Abuse and Mental Health Services Administration (SAMHSA) Buprenorphine Practitioner Locator to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e6f45144066c052e1d4b795b3963f1
https://pubmed.ncbi.nlm.nih.gov/35648731
https://pubmed.ncbi.nlm.nih.gov/35648731
Publikováno v:
Harm reduction journal. 19(1)
Background Prescription opioids have been increasingly prescribed for chronic pain while the opioid-related death rates grow. Naloxone, an opioid antagonist, is increasingly recommended in these patients, yet there is limited research that investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6ea1053024a5b49040046331c005f2
https://pubmed.ncbi.nlm.nih.gov/36138420
https://pubmed.ncbi.nlm.nih.gov/36138420
Autor:
Precious Anyanwu, Tyler J Varisco, Matthew A. Wanat, Shweta Bapat, Kasey Claborn, Douglas Thornton
Aims: To compare county-level differences in the number of buprenorphine prescribers listed in the publicly available Substance Abuse and Mental Health Services Administration (SAMHSA) Buprenorphine Practitioner Locator and in the Drug Enforcement Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d0880db6a6ad4a9135833a2a74774b2
https://doi.org/10.31219/osf.io/vm87b
https://doi.org/10.31219/osf.io/vm87b
